US stocks · Open buy, week 6
Moderna slips 4.5%: a fresh 90-week high the weekly close fails to confirm
Our view last week
Moderna soars 29.1% in a single week: the push that was pressing on recent highs seven days ago has turned into a full acceleration, with the weekly RSI at 85 and the ADX rising for 6 weeks. Moderna stock takes the trade to +37% since entry, with buyers in charge of volume for 4 weeks. Technical analysis calls for caution: the weekly price action flags an extreme exhaustion phase, and chasing here leaves little margin.
This week's summary
A week after its 29.1% surge, Moderna printed a fresh 90-week high and then backed off: the week closed down 4.5%, below the old high. Moderna stock is still up 31% since entry and the trend holds, with the ADX rising for 7 weeks and the weekly RSI at 81. Price action keeps flagging an extreme exhaustion phase: among US stocks with weekly buy signals, this is a swing trading setup to manage, with earnings on October 29 drawing closer.
IQS Phase
74
in tension
Signal Strength
79
high · wide & volatile
Sizing
FULL
Ranking
#12 / 93
US stocks in progress
Trade P&L %
+30.92%
from signal to date, no stop loss
Moderna (MRNA) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 12th among the 93 Longs already running for US stocks in our ranking, with a signal strength of 79 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -2.65% · monthly -3.91%
MRNA belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content